Test Center

My Recent Searches

  • No Recent Search.

My Tests Viewed

  • No Test Viewed.

Showing search results for "thyroid cancer" 21-30 of 83

  1. Lung Cancer Mutation Panel (EGFR, KRAS, ALK)

    This test can be used to help predict the likelihood of response or resistance to targeted therapies (eg, erlotinib, gefitinib) and to assess eligibility for treatment with crizotinib (Xalkori) in patients with non-... More

  2. Colorectal Cancer Mutation Panel (KRAS, PIK3CA, BRAF, NRAS)

    Summarizes information relating to this test including clinical use and background, specimen requirements, methodology, test interpretation, and peer-reviewed references.... More

  3. Prostate Cancer: Laboratory Support for Screening, Diagnosis, and Management

    Provides information relating to prostate cancer including clinical background, individuals suitable for testing, available tests and methodologies, test selection and interpretation, and peer-reviewed references.... More

  4. BRCAvantage, Comprehensive

    This test is used to assess risk of hereditary breast and ovarian cancer syndrome and other BRCA1- and BRCA2-associated hereditary cancers.... More

  5. Lynch Syndrome: Laboratory Support of Diagnosis and Management

    Lynch syndrome, an autosomal dominant disease, is characterized by a high lifetime risk of cancers including colorectal cancer, other gastrointestinal cancers, and endometrial and ovarian cancer. Early diagnosis and ... More

  6. PD-L1 Lung (Pembrolizumab), IHC

    This test is used to identify patients with non-small-cell lung cancer who are eligible for treatment with pembrolizumab.... More

  7. PD-L1 Lung (Nivolumab), IHC

    This test is used to identify patients with advanced nonsquamous, non-small-cell lung cancer who may have enhanced survival following treatment with nivolumab.... More

  8. Colorectal Cancer: Laboratory Support of Diagnosis and Management

    This Clinical Focus reviews selection and interpretation of laboratory tests useful for colorectal cancer screening, diagnosis, prognosis, treatment selection, and monitoring.... More

  9. Lynch Syndrome Panel, Blood

    This test is used to diagnose Lynch syndrome in patients with colorectal or endometrial cancer, high microsatellite instability (MSI), and normal immunohistochemistry (IHC) test results. It is also suitable if ... More

  10. CA 27.29

    This Test Summary provides a brief overview of this test including guidelines-based clinical use, clinical background, individuals suitable for testing, methodology, test interpretation, and specimen requirements.... More

* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.